Risk factors for spontaneous localized intestinal perforation in the preterm infant

References

• Aschner JL, Deluga KS, Metlay LA, et al. Spontaneous focal gastrointestinal perforation in very low birth weight infants. J Pediatr. 1988;113:364–367.
   PubMed Web of Science ®Google Scholar
• Mintz AC, Applebaum H. Focal gastrointestinal perforations not associated with necrotizing enterocolitis in very low birth weight neonates. J Pediatr Surg. 1993;28:857–860.
   PubMed Web of Science ®Google Scholar
• Meyer CL, Payne NR, Roback SA. Spontaneous, isolated intestinal perforations in neonates with birth weight less than 1,000 g not associated with necrotizing enterocolitis. J Pediatr Surg. 1991;26:714–717.
   PubMed Web of Science ®Google Scholar
• Attridge JT, Herman AC, Gurka MJ, et al. Discharge outcomes of extremely low birth weight infants with spontaneous intestinal perforations. J Perinatol. 2006;26:49–54.
   PubMed Web of Science ®Google Scholar
• Holland AJ, Shun A, Martin HC, et al. Small bowel perforation in the premature neonate: congenital or acquired? Pediatr Surg Int. 2003;19:489–494.
   PubMed Web of Science ®Google Scholar
• Paquette L, Friedlich P, Ramanathan R, et al. Concurrent use of indomethacin and dexamethasone increases the risk of spontaneous intestinal perforation in very low birth weight neonates. J Perinatol Off J Calif Perinat Assoc. 2006;26:486–492.
   PubMed Web of Science ®Google Scholar
• Pumberger W, Mayr M, Kohlhauser C, et al. Spontaneous localized intestinal perforation in very-low-birth-weight infants: a distinct clinical entity different from necrotizing enterocolitis. J Am Coll Surg. 2002;195:796–803.
   PubMed Web of Science ®Google Scholar
• Wadhawan R, Oh W, Vohr BR, et al. Spontaneous intestinal perforation in extremely low birth weight infants: association with indometacin therapy and effects on neurodevelopmental outcomes at 18–22 months corrected age. Arch Dis Child Fetal Neonatal Ed. 2013;98:F127–F132.
   PubMed Web of Science ®Google Scholar
• Gordon PV, Attridge JT. Understanding clinical literature relevant to spontaneous intestinal perforations. Am J Perinatol. 2009;26:309–316.
   PubMed Web of Science ®Google Scholar
• Watterberg KL, Gerdes JS, Cole CH, et al. Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: a multicenter trial. Pediatrics. 2004;114:1649–1657.
   PubMed Web of Science ®Google Scholar
• Sharma R, Hudak ML, Tepas JJ, 3rd, et al. Prenatal or postnatal indomethacin exposure and neonatal gut injury associated with isolated intestinal perforation and necrotizing enterocolitis. J Perinatol Off J Calif Perinat Assoc. 2010;30:786–793.
   PubMed Web of Science ®Google Scholar
• Novack CM, Waffarn F, Sills JH, et al. Focal intestinal perforation in the extremely-low-birth-weight infant. J Perinatol. 1994;14:450–453.
   PubMedGoogle Scholar
• Raghuveer G, Speidel B, Marlow N, et al. Focal intestinal perforation in preterm infants is an emerging disease. Acta Paediatr. 1996;85:237–239.
   PubMed Web of Science ®Google Scholar
• Ragouilliaux CJ, Keeney SE, Hawkins HK, et al. Maternal factors in extremely low birth weight infants who develop spontaneous intestinal perforation. Pediatrics. 2007;120:e1458–e1464:e1458-64.
   PubMed Web of Science ®Google Scholar
• Nakajima Y, Masaoka N, Yamamoto T. Obstetrical risk factors for focal intestinal perforation in very low birth weight infants. J Perinat Med. 2011;39:179–184.
   PubMed Web of Science ®Google Scholar
• Shorter NA, Liu JY, Mooney DP, et al. Indomethacin-associated bowel perforations: a study of possible risk factors. J Pediatr Surg. 1999;34:442–444.
   PubMed Web of Science ®Google Scholar
• Ahmad I, Davis K, Emil S, et al. Risk factors for spontaneous intestinal perforation in extremely low birth weight infants. Open Pediatr Med J. 2008;2:11–15.
   Google Scholar
• Parry G, Tucker J, Tarnow-Mordi W. CRIB II: An update of the clinical risk index for babies score. Lancet. 2003;361:1789–1791.
   PubMed Web of Science ®Google Scholar
• Van Overmeire B, Allegaert K, Casaer A, et al. Prophylactic ibuprofen in premature infants: a multicentre, randomised, double-blind, placebo-controlled trial. Lancet. 2004;364:1945–1949.
   PubMed Web of Science ®Google Scholar
• Attridge JT, Clark R, Walker MW, et al. New insights into spontaneous intestinal perforation using a national data set: (1) SIP is associated with early indomethacin exposure. J Perinatol Off J Calif Perinat Assoc. 2006;26:93–99.
   PubMed Web of Science ®Google Scholar
• Schmidt B, Davis P, Moddemann D, et al. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med. 2001;344:1966–1972.
   PubMed Web of Science ®Google Scholar
• Rao R, Bryowsky K, Mao J, et al. Gastrointestinal complications associated with ibuprofen therapy for patent ductus arteriosus. J Perinatol Off J Calif Perinat Assoc. 2011;31:465–470.
   PubMed Web of Science ®Google Scholar
• Sivanandan S, Bali V, Soraisham AS, et al. Effectiveness and safety of indomethacin versus ibuprofen for the treatment of patent ductus arteriosus in preterm infants. Am J Perinatol. 2013;30:745–750.
   PubMed Web of Science ®Google Scholar
• Chan NM, Law CW, Kwan KF Ibuprofen versus indomethacin treatment of patent ductus arteriosus: comparative effectiveness and complications. Hong Kong Med J. 2014; 20:205–212.
   PubMed Web of Science ®Google Scholar
• Ohlsson A, Walia R, Shah SS. Ibuprofen for the treatment of patent ductus arteriosus in preterm and/or low birth weight infants. Cochrane Database Syst Rev. 2010;4:CD003481.
   Google Scholar
• Vermont Oxford Network Steroid Study G. Early postnatal dexamethasone therapy for the prevention of chronic lung disease. Pediatrics. 2001;108:741–748.
   PubMed Web of Science ®Google Scholar
• Stark AR, Carlo WA, Tyson JE, et al. Adverse effects of early dexamethasone treatment in extremely-low-birth-weight infants. National Institute of Child Health and Human Development Neonatal Research Network. N Engl J Med. 2001;344:95–101.
   PubMed Web of Science ®Google Scholar
• Gordon P, Rutledge J, Sawin R, et al. Early postnatal dexamethasone increases the risk of focal small bowel perforation in extremely low birth weight infants. J Perinatol Off J Calif Perinat Assoc. 1999;19:573–577.
   PubMedGoogle Scholar
• Garland JS, Alex CP, Pauly TH, et al. A three-day course of dexamethasone therapy to prevent chronic lung disease in ventilated neonates: a randomized trial. Pediatrics. 1999;104:91–99.
   PubMed Web of Science ®Google Scholar
• Ng PC, Fok TF, So KW, et al. Lower gastrointestinal tract perforation in preterm infants treated with dexamethasone for bronchopulmonary dysplasia. Pediatr Surg Int. 1997;12:211–212.
   Web of Science ®Google Scholar
• Sinkin RA, Dweck HS, Horgan MJ, et al. Early dexamethasone-attempting to prevent chronic lung disease. Pediatrics. 2000;105:542–548.
   PubMed Web of Science ®Google Scholar
• Yeh TF, Lin YJ, Huang CC, et al. Early dexamethasone therapy in preterm infants: a follow-up study. Pediatrics. 1998;101:e7.
   PubMed Web of Science ®Google Scholar
• Shinwell ES, Karplus M, Reich D, et al. Early postnatal dexamethasone treatment and increased incidence of cerebral palsy. Arch Dis Child Fetal Neonatal Ed. 2000;83:F177–F181.
   PubMed Web of Science ®Google Scholar
• Attridge JT, Clark R, Gordon PV. New insights into spontaneous intestinal perforation using a national data set (3): Antenatal steroids have no adverse association with spontaneous intestinal perforation. J Perinatol Off J Calif Perinat Assoc. 2006;26:667–670.
   PubMed Web of Science ®Google Scholar
• Baud O, Maury L, Lebail F, et al. Effect of early low-dose hydrocortisone on survival without bronchopulmonary dysplasia in extremely preterm infants (PREMILOC): a double-blind, placebo-controlled, multicentre, randomised trial. Lancet. 2016;387:1827–1836.
   PubMed Web of Science ®Google Scholar
• Tsukimori K, Yumoto Y, Masumoto K, et al. Ischemic ileal perforation in the donor of monochorionic twins complicated by twin–twin transfusion syndrome. Fetal Diagn Ther. 2009;26:173–176.
   PubMed Web of Science ®Google Scholar
• Philip I, Ford A, Haslam R. Congenital bowel perforation in twin-to-twin transfusion syndrome. Pediatr Surg Int. 2002;18:733–734.
   PubMed Web of Science ®Google Scholar
• Roberts D, Brown J, Medley N, et al. Antenatal corticosteroids for accelerating fetal lung maturation for women at risk of preterm birth. Cochrane Database Syst Rev. 2017;3:CD004454.
   PubMed Web of Science ®Google Scholar